3 Cash-Producing Stocks We Keep Off Our Radar
1 Cash-Heavy Stock to Keep an Eye On and 2 That Underwhelm
3 High-Flying Stocks We Keep Off Our Radar
Despite West Pharmaceutical's underperformance relative to its peers on a YTD basis, Wall Street analysts remain strongly optimistic about the stock’s prospects.
Winners And Losers Of Q4: West Pharmaceutical Services (NYSE:WST) Vs The Rest Of The Drug Development Inputs & Services Stocks
U.S. stocks held steadier as Wall Street waited for the next signal on when the war with Iran may end
3 Reasons to Sell WST and 1 Stock to Buy Instead
EXTON, Pa. , March 9, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) announced today that Eric M. Green has informed the Board of Directors that he plans to retire from his...
1 S&P 500 Stock on Our Watchlist and 2 We Find Risky
EXTON, Pa. , Feb. 27, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will...